Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Long-Term Debt Issuances (2017 - 2026)

Trafalgar International (GCAN) posted Long-Term Debt Issuances of $5000.0 for Q1 2026, down 98.0% on a QoQ basis from $250000.0 in Q2 2021.

Analysis

Trafalgar International (GCAN) Long-Term Debt Issuances (2017 - 2026) Analysis & Trends

Trafalgar International has reported Long-Term Debt Issuances for 6 years, with the latest figure at $5000.0 in Q1 2026.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to $5000.0 in Q1 2026; TTM through Mar 2026 was $255000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $3600.0, changed N/A from the prior year.
  • Long-Term Debt Issuances was $5000.0 for Q1 2026 at Trafalgar International, down from $250000.0 in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $5000.0 in Q1 2026, with the low at $5000.0 in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn -
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 1.98 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 4.88 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn -
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn -
10 Trafalgar International 217,335.05 217,335.05 - 5,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 5,000.00
Jun 30, 2021 250,000.00
Mar 31, 2021 250,000.00
Dec 31, 2020 3,000.00
Sep 30, 2020 -3,000.00
Jun 30, 2020 83,001.00
Mar 31, 2020 426,667.00
Mar 31, 2019 250,000.00
Sep 30, 2018 -20,000.00
Jun 30, 2018 111,127.00
Mar 31, 2018 783.00
Jun 30, 2017 7,443.00
Mar 31, 2017 4,557.00